October 2, 2020
“Kintara Therapeutics (KTRA)… Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the word on the Street is that KTRA is a Strong Buy. Given the… Continue Reading…
October 1, 2020
“When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he’s reaping the rewards. It was the gamble of… Continue Reading…
October 1, 2020
“PDC Energy (PDCE)… Are other analysts in agreement? They are. Only Buy ratings, 11, in fact, have been issued in the last three months. Therefore, the verdict is unanimous: PDCE is a Strong Buy. Given the $21.50 average price target,… Continue Reading…
October 1, 2020
“Solar Senior Capital (SUNS)… The Strong Buy analyst consensus rating on SUNS is unanimous, based on 3 Buy reviews. The stock’s $12.68 trading price and $15.67 average price target give a one-year upside potential of 24%… Barings BDC, Inc. (BBDC)…… Continue Reading…
September 30, 2020
“Seelos Therapeutics (SEEL)… Turning now to the rest of the Street, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, SEEL has a Moderate Buy consensus rating. With the average price target clocking… Continue Reading…
September 30, 2020
“Brickell Biotech (BBI)… Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. As a result, BBI gets a Moderate Buy consensus rating. The $5 average price target is identical… Continue Reading…
September 30, 2020
“Up first is Lam Research Corporation (LRCX), which is a leading semiconductor company that is consistently growing and raising its dividend. When deciding on a strong candidate for long-term dividend growth, I like to look for stocks showing near-term weakness. One-month performance: -5.85% … Continue Reading…
September 29, 2020
“BrainChip Holdings Ltd., an artificial intelligence-focused startup whose flagship product is yet to be made widely available for commercial use, saw its 2020 gains propel to 1,500% earlier this month. While concerns about overheating have seen the stock getting hammered… Continue Reading…
September 29, 2020
“Rekor Systems, Inc. (REKR)… Now that Rekor has taken a plunge back to $5.80 levels, is it still worthwhile investigating the company? Given its 92% quarterly revenue increase as of the most recent results and a debt retirement, I still… Continue Reading…
Recent Comments